Highlight
– Early life stress (ELS) disrupts gut motility and increases visceral pain sensitivity through changes in enteric nervous system (ENS) neurochemistry and sympathetic innervation.
– Sex hormones modulate ELS effects, as shown by reversal of symptoms following gonadal hormone suppression.
– Preclinical findings in mice are supported by human pediatric data linking maternal mental health disorders with heightened risk of disorders of gut-brain interaction (DGBI).
– Targeting sympathetic overactivity and ENS changes offers potential therapeutic avenues for ELS-associated gastrointestinal dysfunction.
Study Background
Disorders of gut-brain interaction (DGBI), such as irritable bowel syndrome and functional dyspepsia, impose a significant clinical burden, particularly when symptoms begin in childhood. Early life stress (ELS), including adverse experiences in infancy or early childhood, is known to influence the development of the gut-brain axis, but the precise mechanisms by which ELS leads to long-term gastrointestinal (GI) dysmotility and visceral pain are not fully understood. The enteric nervous system (ENS), dubbed the “second brain,” regulates gut motility and sensitivity, while the sympathetic nervous system modulates autonomic control of the GI tract. Elucidating how ELS impacts these neural pathways is critical to developing interventions to prevent or ameliorate persistent GI dysfunction stemming from early adverse events.
Study Design
This investigation employed a maternal separation (MS) mouse model to simulate ELS, which involves separating pups from the mother for defined periods during early postnatal life. The study assessed visceral pain sensitivity, intestinal motility, and alterations in ENS composition and sympathetic innervation in these mice. Pharmacological interventions included degarelix to suppress gonadal hormone production, and chemical sympathectomy to probe the role of sympathetic nerves in gut dysfunction. Complementing the preclinical work, two extensive human pediatric cohorts were analyzed for correlations between maternal mental health problems during early life and subsequent pediatric DGBI diagnoses.
Key Findings
Visceral Hypersensitivity and Motility Defects in Mice: MS mice demonstrated significantly increased visceral pain sensitivity compared to controls. Importantly, motility defects were sex-specific, underscoring the influence of biological sex on gut function disturbances following ELS.
Altered ENS Composition: Analysis revealed enhanced serotonergic innervation in the ENS after MS, with shifts in specific neuronal subtypes. Since serotonergic signaling critically modulates gut motility and sensation, these changes likely contribute to the observed phenotypes.
Role of Gonadal Hormones: Treatment with degarelix, which suppresses testosterone and estrogen, reversed visceral pain hypersensitivity and motility abnormalities in MS mice. This finding strongly implicates sex hormones in mediating persistent gut alterations induced by ELS.
Sympathetic Nervous System Overactivity: MS induced increased sympathetic innervation of the gut’s ENS. Subsequent chemical sympathectomy restored normal intestinal motility, demonstrating that sympathetic overactivation plays a causal role in ELS-related gut dysfunction.
Human Correlation: Analysis of two large pediatric cohorts revealed significant associations between maternal mental health disorders and increased risk of pediatric DGBI. These human data mirror the animal model findings, reinforcing the clinical relevance of ELS on gut-brain axis disruption.
Expert Commentary
This study elegantly links early life psychosocial stressors to specific neurobiological mechanisms within the gut and autonomic nervous system, highlighting the interplay between developmental neuroimmune factors and hormonal milieu. The reversal of pathological features via hormone suppression and sympathectomy suggests promising interventional strategies targeting peripheral nervous system components. However, translating these interventions clinically requires careful investigation given the complexity of human psychosocial environments and the multifactorial nature of DGBI.
Limitations include reliance on an animal model that, while well-established, may not capture all dimensions of human ELS, and the observational nature of the human cohorts, which cannot definitively prove causality. Nonetheless, the convergence of preclinical and clinical data strengthens the biological plausibility of ELS as a key driver in pediatric DGBI pathogenesis.
Conclusion
This comprehensive study clarifies how ELS persistently alters gut motility and pain perception through distinct changes in enteric and sympathetic nervous systems, modulated by sex hormones. The mechanistic insights gained hold promise for developing targeted therapies to mitigate or prevent chronic gastrointestinal dysfunction rooted in early adverse experiences. Future research should focus on clinical trials to explore hormone modulation and sympathetic regulation as therapeutic approaches, alongside broader psychosocial support to reduce ELS impact on pediatric populations.
Funding and Clinical Trials
The article does not specify funding sources or clinical trial registrations. Interested readers should consult the original publication for detailed acknowledgments and disclosures.
References
1. Najjar SA, et al. Enteric and Sympathetic Nervous System Pathways Mediate Early Life Stress Effects on Gut Motility and Pain: Mechanistic Findings With Human Correlation. Gastroenterology. 2026;171(1):110-125. doi: 10.1053/j.gastro.2025.11.023.
2. Mayer EA, et al. Gut/brain axis and the microbiota. J Clin Invest. 2015;125(3):926-38.
3. O’Mahony SM, et al. Early life stress and the microbiota-gut-brain axis. Trends Neurosci. 2017;40(2):114-127.
4. Gershon MD. The Second Brain: A Groundbreaking New Understanding of Nervous Disorders of the Stomach and Intestine. HarperCollins; 1999.
